Material Mapper’s vision is to create a market of scale for secondary building materials by mapping them in Europe and leading the transition towards a closed-loop circular construction and demolition industry. The European construction industry is urgently lacking clear, centralized access to information about secondary building materials available in their area, due to the fragmentation and inconsistency with which these public data are captured and stored. This makes building planning with quality secondary building materials time and cost-intensive for stakeholders, in turn making it difficult to comply with the EU’s Waste Directive of 70% recycled/re-used building materials. Our young, multi-award-winning company is planning to launch a project over 24 months to build a breakthrough innovation for the whole of Europe using artificial intelligence and machine learning that will extract, read, evaluate, and forecast quantities of secondary building materials for the user, making future planning for property developers seamless through our platform. We are confident that our product is unique and that we have no direct competition. By combining our deep technology, partnership development, and B2B sales expertise, we are already working closely with major industry actors to harness insights and their existing networks for our customer base.

Propely er et ungt og nytenkende tech-selskap som leverer revolusjonerende programvare til eiendomsbransjen. Vi skiller oss ut ved å levere en sømløs plattform for kommunikasjon mellom utleiere, leietakere og leverandører, en plattform som gir en bedre og mer effektiv drift av eiendommer, samt mer fornøyde brukere av byggene.

Cloud-native microenvironment control for developing & scaling complex cell models. We offer solutions for vertically integrating 2D and 3D assays into your workflow, all the while you maintain real-time control over relevant readouts and variables. Find out more on www.vitroscope.no or reach out under contact@vitroscope.no

Estro has developed a patented solution to improve Fish Health for Norwegian and International Fish farms, the "SeaNest" solution reduce mortality, and facilitate and improve the working environment for both farmer and Fish. A controllable solution for the clean Fish in the Battle against the lice, zero contamination, and no loose parts eliminate the risk of pollution. Easy to Wash and handle. We have signed a full-scale test program with some of the largest companies within the business, and so far with a positive result. First Emission fulfilled mid of 2018, and the commercialization process started.

You shouldn't have to start from zero every time.

Move is an IT infrastructure consulting company and system integrator covering the areas of Network and Security, Virtualization, Database and OS platforms, and high-end server/storage. Move delivers: High expertise advisor and consultancy services Design and implementation of complex projects Diversified service and support services Project Management IT-solutions

Get your products from the manufacturer to the end customer in the fastest and easiest way possible. Regardless of existing volume or size - NBS provides you with the sales channels, systems, and logistics to reach the whole of Norway. IT-system One system for product registration, sales, statistics, and inventory for your products. Fully integrated with all the services you need. Logistics Efficient logistics from a central warehouse in Vestby of 5,500 m2 specially built for handling beverages. Sales to all channels Sell ​​your products under 4.7% alcohol to private customers through Lokalbrygg.no, over 4.7% alcohol to Vinmonopolet, and everything to HoReCa through horecalevering.no. Marketing and Fairs Increase your visibility through our own fairs for HoReCa, private customers, and Vinmonopolet.

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.

Together with four Norwegian hospitals, we have developed the next generation hospital bed. A bed that prevents pressure ulcers, fall and reduce nurse load by removing heavy lifting and monitors the patients state, non intrusive. Have recieved contracts in Toronto that accelerates development, and secures uptake and sales if the clinical trial goes as planned.

From the very beginning, we have been working very closely with the Norwegian construction industry and their construction sites. We have spent a lot of time in the field and on construction sites, we have interviewed decision-makers and users, received their feedback, ideas, and comments, tested mock-ups, and improved. Then back for more testing and more feedback and more improvements. We have organized workshops and been working shoulder to shoulder with the people on site while developing StreamBIM – with one goal: To create a very user-friendly 3D BIM collaboration platform across platforms! Check out https://streambim.com/en/

Noroff has campuses in Oslo, Bergen, Stavanger, and Kristiansand. In addition to the Online study capabilities of nearly all study programs. We offer undergraduate degrees in Digital Forensics and Interactive Media with a specialization in either Animation or Games. All our degrees can be completed as a campus student or through online studies. -> We also offer recognition of prior learning, meaning you can be accredited exemption from course subjects based on prior documented education. We offer vocational diploma degrees in Visual Effects (VFX), FrontEnd Development, 3D Design & Animation, Game Design, 3D Films, Sound & Music, Graphic Design, Film Production, Technical Design, Network, and IT. Apply now at www.noroff.no

Exabel is an artificial intelligence startup based in Oslo, Norway. Exabel’s mission is to synthesize the world’s information and learn how it evolves. We are developing a smart digital assistant software tool for professional investment managers. We are currently a team of 6 full-time employees, with diverse backgrounds; two mathematicians, three software engineers, and a business developer. Combined, we have strong experience with companies like Google, Medallia, Arctic Securities, Intelligent Trading, Microsoft, and Brain Corporation. We are located in Forskningsparken, by StartupLab. The company is well funded for several years of research, product development, and market launch.

Inspired by the sharing economy we're disrupting an old-fashioned industry, saving institutions in the health care sector immense amounts of money and time.uWork is Norway's 1st platform for on-demand healthcare staffing. Launched in May 2016, uWork has already partnered up with more than 50 healthcare institutions in souther Norway, and we're expanding rapidly. Our talent pool of pre-screened healthcare specialists now consists of more than 150 uWorkers, with more signing up every single day.

ZoopIt er en tilbyder av same-day delivery til nettbutikker og lar forbruker få varer levert hjem innen 2 timer etter kjøp i nettbutikken. Vår ambisjon er å tilby en solid, skalerbar tjeneste som lett integreres inn i eksisterende løsninger for å enten erstatte eller supplere tradisjonelle leveranseløsninger. Ønsker du å se tjenesten live kan du besøke handlekurven til en av våre partnere, www.Expert.no. ZoopIt AS ble stiftet I 2014, har i dag 5 ansatte og er deleid av Schibsted.

Seeders is the leading global Authority Marketing Agency, specialising in SEO, Link Building, and Digital PR. A brand’s success greatly depends on its online presence. At Seeders we create international brand visibility for countless companies, on a day-to-day basis. From start-ups to established, international brands. With an ever-growing presence of offices across the globe, we are able to create effective local, as well as global impact in virtually every international market. Time to skyrocket your revenue, through online authority.